Abstract

Multipotent mesenchymal stromal cells (MSC) are receiving increased attention for their non-progenitor immunomodulatory potential. Cryopreservation is commonly used for long-term storage of MSC. Post-thaw MSC proliferation is associated with a lag-phase in vitro. How this lag-phase affect MSC immunomodulatory properties is unknown. We hypothesized that in vitro there is no difference in lymphocyte suppression potential between quick-thawed cryopreserved equine cord blood (CB) MSC immediately included in mixed lymphocyte reaction (MLR) and same MSC allowed post-thaw culture time prior to inclusion in MLR. Cryopreserved CB-MSC from five unrelated foals were compared using two-way MLR. For each of the five unrelated MSC cultures, paired MLR assays of MSC allowed five days of post-thaw culture and MSC included in MLR assay immediately post-thawing were evaluated. We report no difference in the suppression of lymphocyte proliferation by CB-MSC that had undergone post-thaw culture and MSC not cultured post-thaw (p<0.0001). Also, there was no inter-donor variability between the lymphocyte suppressive properties of MSC harvested from the five different donors (p = 0.13). These findings suggest that cryopreserved CB-MSC may have clinical utility immediately upon thawing. One implication hereof is the possibility of using cryopreserved CB-MSC at third party locations without the need for cell culture equipment or competencies.

Highlights

  • Multipotent mesenchymal stromal cells (MSC) are receiving significant attention as a treatment option for various conditions

  • We hypothesized that in vitro there is no difference in lymphocyte suppression potential between post-thaw non-cultured (PTNC) equine cord blood (CB)-MSC immediately included in mixed lymphocyte reaction (MLR) and same MSC allowed post-thaw culture (PTC) prior to inclusion in MLR

  • CB-MSC suppressed lymphocyte proliferation compared to the positive control, Figure 1 (p,0.0001)

Read more

Summary

Introduction

Multipotent mesenchymal stromal cells (MSC) are receiving significant attention as a treatment option for various conditions. Progenitor cell integration into recipient tissues has only been observed in very small numbers challenging the importance of the MSC progenitor paradigm [1]–[3]. Di Nicola et al [4] observed MSC-mediated lymphocyte suppression occurred in a MSC-dose dependent, time independent, and reversible manner that did not require cell-to-cell contact in vitro. These findings resulted in a paradigm shift—from progenitor to non-progenitor functions—as a main mechanism by which undifferentiated MSC exerts therapeutic effect. Non-progenitor MSC actions that have been investigated include cell-to-cell fusion [5]–[7], organelle transfer [8],[9], reactive oxygen scavenge [10]–[13], and suppression of lymphocyte proliferation [4],[14],[15]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call